BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33806890)

  • 1. Determinants of Population-Based Cancer Screening Performance at Primary Healthcare Institutions in China.
    Zheng S; Zhang X; Greuter MJW; de Bock GH; Lu W
    Int J Environ Res Public Health; 2021 Mar; 18(6):. PubMed ID: 33806890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Willingness of healthcare providers to perform population-based cancer screening: a cross-sectional study in primary healthcare institutions in Tianjin, China.
    Zheng S; Zhang X; Greuter MJW; de Bock GH; Lu W
    BMJ Open; 2024 Apr; 14(4):e075604. PubMed ID: 38569674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined patterns of participation in cervical, breast, and colorectal cancer screenings and factors for non-participation in each screening among women in Japan.
    Ishii K; Tabuchi T; Iso H
    Prev Med; 2021 Sep; 150():106627. PubMed ID: 34019930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does mammogram attendance influence participation in cervical and colorectal cancer screening? A prospective study among 1856 French women.
    Bertaut A; Coudert J; Bengrine L; Dancourt V; Binquet C; Douvier S
    PLoS One; 2018; 13(6):e0198939. PubMed ID: 29927995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invitation coverage and participation in Italian cervical, breast and colorectal cancer screening programmes.
    Giorgi Rossi P; Carrozzi G; Federici A; Mancuso P; Sampaolo L; Zappa M
    J Med Screen; 2018 Mar; 25(1):17-23. PubMed ID: 28614991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Socioeconomic and healthcare use-related determinants of cervical, breast and colorectal cancer screening practice in the French West Indies.
    Menvielle G; Dugas J; Richard JB; Luce D
    Eur J Cancer Prev; 2018 May; 27(3):269-273. PubMed ID: 27824663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer screening utilization by residence and sexual orientation.
    Lee M; Jenkins WD; Adjei Boakye E
    Cancer Causes Control; 2020 Oct; 31(10):951-964. PubMed ID: 32833199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer screening participation in schizophrenic outpatients and the influence of their functional disability on the screening rate: A cross-sectional study in Japan.
    Fujiwara M; Inagaki M; Nakaya N; Fujimori M; Higuchi Y; Hayashibara C; So R; Kakeda K; Kodama M; Uchitomi Y; Yamada N
    Psychiatry Clin Neurosci; 2017 Dec; 71(12):813-825. PubMed ID: 28875514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on the coverage of cervical and breast cancer screening among women aged 35-69 years and related impact of socioeconomic factors in China, 2013].
    Bao HL; Wang LH; Wang LM; Fang LW; Zhang M; Zhao ZP; Cong S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):208-212. PubMed ID: 29495207
    [No Abstract]   [Full Text] [Related]  

  • 10. Factors promoting breast, cervical and colorectal cancer screenings participation: A systematic review.
    Vallone F; Lemmo D; Martino ML; Donizzetti AR; Freda MF; Palumbo F; Lorenzo E; D'Argenzio A; Caso D
    Psychooncology; 2022 Sep; 31(9):1435-1447. PubMed ID: 35793430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors for non-participation or partial participation in breast, cervical and colorectal cancer screening programmes†.
    Dawidowicz S; Le Breton J; Moscova L; Renard V; Bercier S; Brixi Z; Audureau E; Clerc P; Bastuji-Garin S; Ferrat E
    Fam Pract; 2020 Feb; 37(1):15-24. PubMed ID: 31305884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR Consortium.
    Barlow WE; Beaber EF; Geller BM; Kamineni A; Zheng Y; Haas JS; Chao CR; Rutter CM; Zauber AG; Sprague BL; Halm EA; Weaver DL; Chubak J; Doria-Rose VP; Kobrin S; Onega T; Quinn VP; Schapira MM; Tosteson ANA; Corley DA; Skinner CS; Schnall MD; Armstrong K; Wheeler CM; Silverberg MJ; Balasubramanian BA; Doubeni CA; McLerran D; Tiro JA
    J Natl Cancer Inst; 2020 Mar; 112(3):238-246. PubMed ID: 31292633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge, attitudes and behaviors of breast and cervical cancers and screenings of women working in primary health care services.
    Deniz S; Coskun F; Oztas D; Kurt AO
    J BUON; 2018 Dec; 23(7):44-52. PubMed ID: 30722111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. County-Level Social Vulnerability and Breast, Cervical, and Colorectal Cancer Screening Rates in the US, 2018.
    Bauer C; Zhang K; Xiao Q; Lu J; Hong YR; Suk R
    JAMA Netw Open; 2022 Sep; 5(9):e2233429. PubMed ID: 36166230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast, Cervical, and Colorectal Cancer Screening: Patterns Among Women With Medicaid and Commercial Insurance.
    Bonafede MM; Miller JD; Pohlman SK; Troeger KA; Sprague BL; Herschorn SD; Winer IH
    Am J Prev Med; 2019 Sep; 57(3):394-402. PubMed ID: 31377088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Screening Test Use-U.S., 2019.
    Sabatino SA; Thompson TD; White MC; Shapiro JA; Clarke TC; Croswell JM; Richardson LC
    Am J Prev Med; 2022 Sep; 63(3):431-439. PubMed ID: 35469700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium.
    Tosteson AN; Beaber EF; Tiro J; Kim J; McCarthy AM; Quinn VP; Doria-Rose VP; Wheeler CM; Barlow WE; Bronson M; Garcia M; Corley DA; Haas JS; Halm EA; Kamineni A; Rutter CM; Tosteson TD; Trentham-Dietz A; Weaver DL;
    J Gen Intern Med; 2016 Apr; 31(4):372-9. PubMed ID: 26658934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening Beyond the Evidence: Patterns of Age and Comorbidity for Breast, Cervical, and Colorectal Cancer Screening.
    Onega T; Garcia M; Beaber EF; Haas JS; Breslau ES; Tosteson ANA; Halm E; Chao CR; Barlow WE
    J Gen Intern Med; 2024 Jun; 39(8):1324-1331. PubMed ID: 38097863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population-based survey of self-reported delays in breast, cervical, colorectal and lung cancer screening.
    Gunn CM; Berrian K; Weiss JE; Tosteson AAN; Hasson RM; Di Florio-Alexander R; Peacock JL; Rees JR
    Prev Med; 2023 Oct; 175():107649. PubMed ID: 37517458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to increase uptake in oncologic screening: a systematic review of studies comparing population-based screening programs and spontaneous access.
    Ferroni E; Camilloni L; Jimenez B; Furnari G; Borgia P; Guasticchi G; Giorgi Rossi P;
    Prev Med; 2012 Dec; 55(6):587-96. PubMed ID: 23064024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.